Costs and effects in therapy for acute coronary syndromes: The case of abciximab in high-risk patients undergoing percutaneous transluminal coronary angioplasty in the EPIC study

Ben A. van Hout, Lee Bowman, David J. Zelinger, Maarten L. Simoons

American Heart Journal · 1998 · 24 citations · 16 references

Concepts

References

16